Viewing Study NCT04828161


Ignite Creation Date: 2025-12-24 @ 12:06 PM
Ignite Modification Date: 2025-12-29 @ 6:53 PM
Study NCT ID: NCT04828161
Status: TERMINATED
Last Update Posted: 2023-01-18
First Post: 2021-03-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MP0420-CP302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View